Document is current
Any future updates will be listed below
-
Authors
Guma, Monica
Dadpey, Benyamin
Coras, Roxana
Mikuls, Ted R.
Hamilton, Bartlett
Quehenberger, Oswald
Thorisdottir, Hilda
Bittleman, David
Lauro, Kimberly
Reilly, Shannon M.
Liu-Bryan, Ru
Terkeltaub, Robert https://orcid.org/0000-0001-5368-7473
-
Funding
Funding for this research was provided by:
National Institutes of Health (AR073324)
National Institutes of Health (T32AR064194)
National Institutes of Health (DK126944)
National Institutes of Health (AR060772)
National Institutes of Health (AR075990)
Veterans Affairs San Diego Healthcare System
- License Information
-
More Information
Article History
Received: 7 June 2021
Accepted: 26 June 2022
First Online: 25 July 2022
Declarations
:
: The clinical trial and ancillary study were approved by the VA Institutional Board Review, and all subjects signed an informed written consent for both studies.
: Not applicable.
: RT: research grant: Astra-Zeneca; consulting: SOBI, Selecta, Horizon, Allena, Astra-ZenecaMG: research grant: Pfizer, NovartisRLB, RC, SMR, BD, HT, DB, KL: none
